•
Sep 30, 2024

CME Group Q3 2024 Earnings Report

CME Group reported all-time record revenue, adjusted operating income, adjusted net income, and adjusted earnings per share.

Key Takeaways

CME Group reported a record-breaking Q3 2024, achieving all-time high revenue of $1.6 billion and an operating income of $1.0 billion. Net income reached $913 million, with diluted earnings per share at $2.50. Adjusted net income was $977 million, and adjusted diluted earnings per share were $2.68.

CME Group's Q3 2024 was the best quarter in its history, marked by records in volume, revenue, adjusted operating income, adjusted net income, and adjusted earnings per share.

The company saw the second consecutive quarter of volume and open interest increases across every asset class.

Financial product volumes increased by 28%, driven by a 36% rise in interest rates, reaching a record ADV of 14.9 million contracts.

Commodities volume was up 20%, options increased 27%, and international ADV reached a record 8.4 million contracts.

Total Revenue
$1.58B
Previous year: $1.34B
+18.4%
EPS
$2.68
Previous year: $2.25
+19.1%
Average Daily Volume
28.3M
Previous year: 22.3M
+26.9%
Average Rate Per Contract
$0.666
Previous year: $0.707
-5.8%
Gross Profit
$1.37B
Previous year: $1.13B
+20.6%
Cash and Equivalents
$2.32B
Previous year: $2.3B
+1.0%
Free Cash Flow
$973M
Previous year: $837M
+16.3%
Total Assets
$138B
Previous year: $126B
+9.7%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

No specific forward guidance was provided in the document.

Revenue & Expenses

Visualization of income flow from segment revenue to net income